AI Image
Blood pressure medicine recall: Thousands of bottles pulled nationwide
Fox Business • • general
Key Points:
- Macleods Pharma USA is recalling certain lots of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide tablets nationwide due to failure to meet federal quality standards, specifically failing dissolution specifications.
- The recall includes 3,528 bottles of 30-count (NDC 33342-246-07) and 216 bottles of 90-count (NDC 33342-246-10), both expiring May 31, 2027.
- The FDA classified the recall as Class II, indicating the medication may cause temporary or reversible health effects, but serious health consequences are unlikely.
- This recall follows a similar recent recall of chlorthalidone tablets by Inventia Healthcare Ltd. for failing dissolution testing, highlighting ongoing concerns about blood pressure medication quality.
- Consumers are advised to check their medication bottles for the specified lot numbers and NDC codes and consult healthcare providers if they have concerns.
